Edward Francis Fritsch, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cancer Vaccines | 15 | 2024 | 1044 | 2.320 |
Why?
|
| Antigens, Neoplasm | 12 | 2024 | 2002 | 1.430 |
Why?
|
| Neoplasms | 9 | 2024 | 22340 | 0.580 |
Why?
|
| Epitopes | 2 | 2021 | 2523 | 0.560 |
Why?
|
| Melanoma | 8 | 2024 | 5719 | 0.490 |
Why?
|
| Vaccines | 1 | 2022 | 841 | 0.440 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2014 | 825 | 0.360 |
Why?
|
| Immunotherapy | 6 | 2024 | 4752 | 0.350 |
Why?
|
| T-Lymphocytes | 4 | 2024 | 10261 | 0.350 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 1365 | 0.280 |
Why?
|
| Antigen-Presenting Cells | 2 | 2022 | 962 | 0.160 |
Why?
|
| HLA Antigens | 3 | 2022 | 1339 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 4405 | 0.160 |
Why?
|
| Vaccination | 2 | 2022 | 3426 | 0.160 |
Why?
|
| Epitope Mapping | 1 | 2019 | 300 | 0.150 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2018 | 89 | 0.150 |
Why?
|
| Immunity, Cellular | 2 | 2014 | 1555 | 0.150 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2019 | 1441 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2020 | 371 | 0.140 |
Why?
|
| Substrate Specificity | 1 | 2021 | 1752 | 0.140 |
Why?
|
| Immune System | 1 | 2022 | 799 | 0.140 |
Why?
|
| Immunologic Memory | 2 | 2021 | 1375 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2021 | 2570 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2018 | 903 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2018 | 959 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2021 | 4642 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2194 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2018 | 3459 | 0.090 |
Why?
|
| Immunity, Innate | 1 | 2022 | 3081 | 0.080 |
Why?
|
| Skin Neoplasms | 2 | 2022 | 5849 | 0.080 |
Why?
|
| Mutation | 4 | 2024 | 30198 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 1646 | 0.070 |
Why?
|
| Humans | 20 | 2024 | 765968 | 0.070 |
Why?
|
| Animals | 4 | 2024 | 168764 | 0.070 |
Why?
|
| Mice | 2 | 2024 | 81819 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4209 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2589 | 0.060 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 3946 | 0.050 |
Why?
|
| HLA-D Antigens | 1 | 2019 | 130 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 207 | 0.040 |
Why?
|
| Algorithms | 2 | 2019 | 14071 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 446 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2014 | 1801 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 2018 | 342 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2018 | 737 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1106 | 0.030 |
Why?
|
| Protein Binding | 2 | 2019 | 9296 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2022 | 6113 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1250 | 0.030 |
Why?
|
| Phenotype | 2 | 2022 | 16721 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 17075 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 4165 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2014 | 517 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2018 | 1963 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6499 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2535 | 0.020 |
Why?
|
| Placenta | 1 | 2018 | 1728 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4260 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2796 | 0.020 |
Why?
|
| Antigens | 1 | 2014 | 1438 | 0.020 |
Why?
|
| Alleles | 1 | 2019 | 6897 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 2176 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5786 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 13400 | 0.020 |
Why?
|
| Software | 1 | 2019 | 4462 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3655 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2018 | 4424 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11888 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 18973 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2747 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9525 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5389 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 3111 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9373 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 171117 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 30260 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 223009 | 0.010 |
Why?
|
| Female | 3 | 2020 | 396112 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 59889 | 0.010 |
Why?
|
| Male | 2 | 2020 | 363698 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 223044 | 0.000 |
Why?
|